114-42-1

Basic information

• Product Name: flavaspidic acid
• Synonyms: flavaspidic acid;3,5-Dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-[[2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-2,5-cyclohexadien-1-one;3,5-Dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-[[2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-2,5-cyclohexadiene-1-one;Flavaspidic acid BB;Polystichocitrin;Toxifren
• CAS NO: 114-42-1
• Molecular Formula: C₂₄H₃₀O₈
• Molecular Weight: 446.493
• Mol File: 114-42-1.mol
• Article Data: 2

Chemical Properties

• Melting Point: 92°C
• Boiling Point: 475.85°C (rough estimate)
• Flash Point: 404.3°C
• Appearance: /
• Density: 1.1947 (rough estimate)
• Vapor Pressure: 1.56E-21mmHg at 25°C
• Refractive Index: 1.4480 (estimate)
• CAS DataBase Reference: flavaspidic acid(CAS DataBase Reference)
• NIST Chemistry Reference: flavaspidic acid(114-42-1)
• EPA Substance Registry System: flavaspidic acid(114-42-1)

Safety Data

• Hazardous Substances Data: 114-42-1(Hazardous Substances Data)

Usage

General Description

Flavaspidic acid is a natural organic compound found in various species of plants, particularly in the Asclepiadaceae family. It is known for its antibacterial properties and has been studied for its potential as an antibacterial agent. It has been found to be effective against various strains of bacteria, including drug-resistant strains, making it a promising candidate for the development of new antibiotics. Additionally, flavaspidic acid has been found to exhibit anti-inflammatory and anti-tumor properties, further expanding its potential as a therapeutic agent in the treatment of various diseases and conditions. However, further research is needed to fully understand its mechanisms of action and to explore its potential applications in medicine and healthcare.

InChI:InChI=1/C24H30O8/c1-6-8-14(25)16-19(28)11(3)18(27)12(20(16)29)10-13-21(30)17(15(26)9-7-2)23(32)24(4,5)22(13)31/h27-31H,6-10H2,1-5H3

Upstream product

• 50-00-0 formaldehyd 
• 1509-06-4 1-[3-methyl-2,4,6-trihydroxyphenyl]-1-butanone 
• 20054-04-0 4-butyryl-2,2-dimethyl-cyclohexane-1,3,5-trione 
• 621-23-8 1,2,3-trimethoxybenzene 
• 830-79-5 2,4,6-trimethoxybenzaldehyde 
• 14107-97-2 2,4,6-trimethoxytoluene 
• 108-73-6 3,5-dihydroxyphenol 
• 4133-77-1 4,4-dimethyl-3,5-dihydroxy-2-butanoyl-2,5-cyclohexadienone 
• 33797-51-2 eschenmoser's salt 
• 3098-40-6 1,1’-(2,4,6-trihydroxy-1,3-phenylene)bis(butan-1-one) 
• 487-70-7 2,4,6-trihydroxybenzaldehyde 

Related news

Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid (cas 114-42-1) AB08/21/2019

Porcine reproductive and respiratory syndrome virus (PRRSV) represents a significant challenge to the swine industry worldwide. Current control strategies against PRRSV are still inadequate and there is an urgent need for new antiviral therapies. Flavaspidic acid AB (FA-AB) is a compound derived...detailed

Relevant articles and documents

A natural product yellow filicic acid BB of full-synthesis method

The invention relates to a natural product yellow filicic acid BB of full-synthesis method, which belongs to the technical field of organic chemistry. The invention from the economic and easy to synthesize the phloroglucinol proceed double-acylated phloroglucinol, then after iodine methane-to-carbon double methylation, removing monomolecular acyl got the midbody 3; to phloroglucinol as raw materials, acetate acylation to obtain the aldehyde phloroglucinol, reduction of the aldehyde is methyl, then acylated to obtain intermediate 6; the two fragments obtained through the Eschenmoser's salt combined yellow filicic acid BB. In the method 42% overall yield of yellow filicic acid improves the BB fully synthetic yield, raw material economy are easy, simple operation, high yield, and suitable for production, may be its biological activity study provide a large number of raw materials.